Plebani M. Appropriateness in programs for continuous quality improvement in clinical laboratories. Clin Chim Acta2003; 333: 131–9.
Burke MD. Clinical laboratory consultation: appropriateness to laboratory medicine. Clin Chim Acta2003; 333: 125–9.
Siest G. First Santorini Conference: from genetic variations to risk prediction and pharmacogenomics. Clin Chem Lab Med2003; 41: 397.
Price CP. Evidence-based laboratory medicine: supporting decision-making. Clin Chem2000; 46: 1041–50.
WD. Outcomes research in diagnostics: not yet. In Vivo 1995;Jan:11–7.
Moyer TP. Competitive bidding and clinical laboratory services. Why it doesn't make sense. Clin Lab News2004; 30: 4.
Plebani M. The changing face of clinical laboratories. Clin Chem Lab Med1999; 37: 711–7.
Plebani M. Charting the course of medical laboratories in a changing environment. Clin Chim Acta2002; 319: 87–100.
Price CP. Point of care testing. Br Med J2001; 322: 1285–8.
Hoezel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, et al. IFCC Working Group on HbA1c Standardization. IFCC reference system for measurement of haemoglobin A1c in human blood and the nationalstandardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem2004; 50: 166–74.
Home P, Mbanya JC, Horton E. Standardisation of glycated haemoglobin. Br Med J2004; 329: 1196–7.
Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frolich J, Jungner I, et al. Apolipoproteins versus lipids as indices of coronary risk and as targets forstatin therapy: analysis of the evidence. Lancet2003; 361: 777–80.
Walldius G, Jungner I, Aasveit AH, Holme I, Furberg CD, Sniderman AD. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance betweenplasma proatherogenic and antiatherogenic lipoproteinsand to predict coronary risk. Clin Chem Lab Med2004; 42: 1355–63.
Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH. International Federation of Clinical Chemistry Standardization project for measurements of apolipoproteins A-I and B. IV Comparability of apolipoprotein B values by use of international reference material. Clin Chem1994; 40: 586–92.
Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med2005; 142: 786–91.
Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J2003; 146: 446–52.
Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al., on behalf of the Committee on Standardization of Markers of Cardiac Damage of the IFCC. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem2004; 50: 327–32.
Wu AH, Apple FS, Gibler WB, Jesse RL, Warchaw MM, Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice. Recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem1999; 45: 1104–21.
Plebani M. What information on quality specifications should be communicated to physicians, and how? Clin Chim Acta2004; 346: 25–36.
Moons KG, Biesheuvel CJ, Grobbee DE. Test research versus diagnostic research. Clin Chem2004; 50: 473–6.
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwing LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem2003; 49: 1–6.
Gill CJ, Sabin L, Schmidt CH. Why clinicians are natural Bayesians. Br Med J2005; 330: 1080–3.
Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, et al. D-Dimer for the exclusion of acute venous thrombosis and pulmonary embolism. Ann Intern Med2004; 140: 589–602.
Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet2005; 365: 1163–74.
Galen RS, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnoses. New York: John Wiley & Sons, 1975.
Institute of Medicine. Crossing the quality chasm. Washington, DC: National Academy Press, 2001.
Muir Gray JA. Knowledge management: an essential focus for the effective clinical laboratory. Clin Chim Acta2005; 355: S19.